Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio‐oncology units in Europe and a grow...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ESC Heart Fail
Asıl Yazarlar: Anker, Markus S., Hadzibegovic, Sara, Lena, Alessia, Belenkov, Yury, Bergler‐Klein, Jutta, de Boer, Rudolf A., Farmakis, Dimitrios, von Haehling, Stephan, Iakobishvili, Zaza, Maack, Christoph, Pudil, Radek, Skouri, Hadi, Cohen‐Solal, Alain, Tocchetti, Carlo G., Coats, Andrew J.S., Seferović, Petar M., Lyon, Alexander R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
ESC and HFA Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989292/
https://ncbi.nlm.nih.gov/pubmed/31884717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12551
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller